カテゴリ： , , GlobalData

GAIL (India) Ltd (GAIL)

◆英語タイトル：GAIL (India) Ltd (GAIL) - Financial and Strategic SWOT Analysis Review
◆商品コード：SWOT20MY0037
◆発行会社（調査会社）：GlobalData
◆発行日：2019
◆ページ数：61
◆レポート言語：
◆レポート形式：PDF
◆納品方法：E
◆対象地域：
◆産業分野：Oil and Gas
◆販売価格オプション（消費税別）
Single UserUSD125 ⇒換算￥18,500見積依頼/購入/質問フォーム
Site LicenseUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Enterprisewide LicenseUSD375 ⇒換算￥55,500見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

GAIL (India) Ltd (GAIL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
GAIL (India) Ltd – Key Facts
GAIL (India) Ltd – Key Employees
GAIL (India) Ltd – Key Employee Biographies
GAIL (India) Ltd – Major Products and Services
GAIL (India) Ltd – History
GAIL (India) Ltd – Company Statement
GAIL (India) Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Joint Venture
Section 2 ? Company Analysis
Company Overview
GAIL (India) Ltd – Business Description
Business Segment: LPG and Other Liquid Hydrocarbons
Overview
Performance
Key Stats
Business Segment: Natural Gas Marketing
Overview
Performance
Key Stats
Business Segment: Others
Overview
Performance
Key Stats
Business Segment: Petrochemicals
Overview
Performance
Key Stats
Business Segment: Transmission Services
Overview
Performance
Key Stats
GAIL (India) Ltd – Corporate Strategy
GAIL (India) Ltd – SWOT Analysis
SWOT Analysis – Overview
GAIL (India) Ltd – Strengths
GAIL (India) Ltd – Weaknesses
GAIL (India) Ltd – Opportunities
GAIL (India) Ltd – Threats
GAIL (India) Ltd – Key Competitors
Section 3 ? Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 ? Company

List of Tables
GAIL (India) Ltd, Key Facts
GAIL (India) Ltd, Key Employees
GAIL (India) Ltd, Key Employee Biographies
GAIL (India) Ltd, Major Products and Services
GAIL (India) Ltd, History
GAIL (India) Ltd, Other Locations
GAIL (India) Ltd, Subsidiaries
GAIL (India) Ltd, Affiliate
GAIL (India) Ltd, Joint Venture
GAIL (India) Ltd, Key Competitors
GAIL (India) Ltd, Ratios based on current share price
GAIL (India) Ltd, Annual Ratios
GAIL (India) Ltd, Annual Ratios (Cont...1)
GAIL (India) Ltd, Annual Ratios (Cont...2)
GAIL (India) Ltd, Interim Ratios
GAIL (India) Ltd, Oil & Gas, Deals By Year, 2013 to YTD 2019
GAIL (India) Ltd, Oil & Gas, Deals By Type, 2013 to YTD 2019
GAIL (India) Ltd, Recent Deals Summary
Currency Codes
Units
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
GAIL (India) Ltd, Performance Chart (2015 - 2019)
GAIL (India) Ltd, Ratio Charts
GAIL (India) Ltd, Oil & Gas, Deals By Year, 2013 to YTD 2019
GAIL (India) Ltd, Oil & Gas, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[GAIL (India) Ltd (GAIL)]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • ING Groep NV：戦略・SWOT・企業財務分析
    ING Groep NV - Strategy, SWOT and Corporate Finance Report Summary ING Groep NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • The National Commercial Bank：企業の戦略・SWOT・財務分析
    The National Commercial Bank - Strategy, SWOT and Corporate Finance Report Summary The National Commercial Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Holtec International Inc：企業の戦略的SWOT分析
    Holtec International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Cleanup Corporation (7955)：企業の財務・戦略的SWOT分析
    Cleanup Corporation (7955) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Energy Fuels Inc (EFR)：企業の財務・戦略的SWOT分析
    Energy Fuels Inc (EFR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Centre for Drug Design and Discovery：製薬・医療：M&Aディール及び事業提携情報
    Summary Centre for Drug Design and Discovery (CD3) is a biomedical research institution that discovers new small molecule drugs. The institution operates as an investment fund and technology transfer platform to promote the discovery and development of medicines for all kinds of diseases. It provide …
  • Royal DSM N.V.：企業のM&A・事業提携・投資動向
    Royal DSM N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Royal DSM N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Zosano Pharma Corp (ZSAN)：企業の財務・戦略的SWOT分析
    Summary Zosano Pharma Corp (Zosano Pharma), formerly ZP Holdings Inc, is a clinical stage biopharmaceutical company that develops proprietary transdermal delivery system. The company develops a transdermal microneedle patch system to deliver its drug formulations through the skin for the treatment o …
  • VentriPoint Inc：製品パイプライン分析
    Summary VentriPoint Inc (VentriPoint), a subsidiary of VentriPoint Diagnostics Ltd is a medical device company that manufactures and distributes medical devices for the cardiovascular market. The company’s product VMS is a heart visualization system which is used to evaluate right heart function. It …
  • Complix NV：製薬・医療：M&Aディール及び事業提携情報
    Summary Complix NV (Complix) is a biopharmaceutical company that discovers and develops alphabodies and pre-clinical programs. The company’s products comprise CMPX-1023, a novel alphabody for autoimmune diseases, and cell penetrating alphabodies for the treatment of cancer, among others. It designs …
  • IBIDEN CO., LTD.：戦略・SWOT・企業財務分析
    IBIDEN CO., LTD. - Strategy, SWOT and Corporate Finance Report Summary IBIDEN CO., LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • China Petroleum & Chemical Corporation (600028)-石油・ガス分野：企業M&A・提携分析
    Summary China Petroleum & Chemical Corporation (Sinopec), a subsidiary of China Petrochemical Corporation, is a vertically integrated energy and chemical company. It is involved in the oil and gas exploration and production, extraction, pipeline transmission and marketing; oil refining; and producti …
  • Precision Optics Corporation Inc (PEYE)-医療機器分野：企業M&A・提携分析
    Summary Precision Optics Corporation Inc (Precision Optics) is a medical device company that designs, develops, manufactures and distributes optics and optical systems for medical, biomedical, and industrial applications. The company offers custom optics solutions such as design and prototyping, fib …
  • Millendo Therapeutics Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Millendo Therapeutics Inc (Millendo Therapeutics), formerly Atterocor Inc is a drug development company that develops treatments for endocrine diseases including vasomotor. The company provides development of innovative treatments for orphan endocrine disorders such as adrenocortical carcino …
  • MolecularMD Corp：医療機器：M&Aディール及び事業提携情報
    Summary MolecularMD Corp (MMD) is a diagnostics solution provider that develops and commercialize molecular diagnostic tests, which are deployed and leveraged across the continuum of the drug development process. The company offers assay design and development services, sample banking and bridging s …
  • SymBio Pharmaceuticals Ltd (4582)：企業の財務・戦略的SWOT分析
    Summary SymBio Pharmaceuticals Ltd (SymBio) is a biopharmaceutical company that develops and markets anti-cancer drug candidates. Its pipeline product portfolio includes Treakisym (SyB L-0501), an anti-cancer agent used for the treatment of non-Hodgkin's lymphoma (NHL), multiple myeloma (MM) and chr …
  • Hague and London Oil PLC (HNL)：企業の財務・戦略的SWOT分析
    Summary Hague and London Oil PLC (HALO), formerly Wessex Exploration plc, is an oil and gas exploration company that develops resource properties. The company acquires, explores, produces, and develops oil and gas resource properties across the UK. Its projects comprise assets in the Philippines, Gu …
  • Ignyta Inc：医療機器：M&Aディール及び事業提携情報
    Summary Ignyta Inc (Ignyta), formerly NexDx Inc, a subsidiary of F. Hoffmann-La Roche Ltd, is a cancer care service provider. The company discovers, develops and commercializes new drugs targeting activated genes in cancer cells. It develops products using integrated therapeutic technology (Rx/Dx). …
  • Bristol-Myers Squibb Co (BMY)-医療機器分野：企業M&A・提携分析
    Summary Bristol-Myers Squibb Company (BMS) is specialty biopharmaceutical company that carries out the discovery, development, licensing, manufacturing, marketing, distribution and sale of medicines to patients with serious diseases. Its primary focus is in cancer, cardiovascular, immunoscience and …
  • Genmab AS (GEN)：製薬・医療：M&Aディール及び事業提携情報
    Summary Genmab A/S (Genmab) is a biotechnology company that develops differentiated human antibody therapeutics for the treatment of cancer. The company's marketed antibody, ofatumumab (Arzerra) and Daratumumab (Darzalex) are indicated for the treatment of chronic lymphocytic leukemia and multiple m …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆